wikidoc - Recent changes [en]

Hibatullah Abdul Aleem

2026-04-29T16:04:52Z

Created page with "__NOTOC__ ==Hibatullah Abdul Aleem== '''Hibatullah Abdul Aleem''' Contact: Email: [mailto:dr.hibatullah8@gmail.com] ==Current Position== ==Professional Background== ==Education== M.B.B.S fron Shadan Institute Of Medical Sciences ==Brief Biography=="

New page

__NOTOC__
==Hibatullah Abdul Aleem==
'''Hibatullah Abdul Aleem'''
 Contact: 
Email: [mailto:dr.hibatullah8@gmail.com] 

==Current Position==

==Professional Background==

==Education==
M.B.B.S fron Shadan Institute Of Medical Sciences

==Brief Biography==

Sandbox

2026-04-29T10:11:34Z

Replaced content with "== '''Thoracic Aortic Aneurysm Medical Therapy''' == <references />"

Show changes

Thoracic aortic aneurysm medical therapy

2026-04-29T10:10:34Z

Medical Therapy

Show changes

SANDBOX:HT

2026-04-29T10:02:24Z

Created page with "HEADING"

New page

[[HEADING]]

Template:HT

2026-04-29T09:46:56Z

Created page with "Hibatullah Abdul Aleem, M.B.B.S[mailto:dr.hibatullah8@gmail.com]"

New page

[[User:Hibatullah Abdul Aleem|Hibatullah Abdul Aleem, M.B.B.S]][mailto:dr.hibatullah8@gmail.com]

Datopotamab deruxtecan-dlnk

2026-04-28T18:44:41Z

← Older revision		Revision as of 18:44, 28 April 2026
Line 292:		Line 292:

	* Store vials in a refrigerator at 2ºC to 8ºC (36ºF to 46ºF) in the original carton to protect from light until time of reconstitution. Do not freeze. Do not shake the reconstituted or diluted solution.		* Store vials in a refrigerator at 2ºC to 8ºC (36ºF to 46ºF) in the original carton to protect from light until time of reconstitution. Do not freeze. Do not shake the reconstituted or diluted solution.
			[[File:Datopotamab display panel.jpeg\|400px\|thumb\|right\|Principle Display Panel]]

	* DATROWAY (datopotamab deruxtecan-dlnk) is a hazardous drug. Follow applicable special handling and disposal procedures.		* DATROWAY (datopotamab deruxtecan-dlnk) is a hazardous drug. Follow applicable special handling and disposal procedures.

File:Datopotamab display panel.jpeg

2026-04-28T14:09:42Z

Anum Ijaz uploaded File:Datopotamab display panel.jpeg

New page

Sandbox

2026-04-28T01:40:03Z

← Older revision		Revision as of 01:40, 28 April 2026
Line 30:		Line 30:
	* [[Statin\|Statins]]: high-intensity statin therapy for atherosclerotic TAA		* [[Statin\|Statins]]: high-intensity statin therapy for atherosclerotic TAA

	== 2022 ACC/AHA Guidelines for the Diagnosis and Management of Aortic Disease <ref name="pmid36334952">{{cite journal \|vauthors=Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ \|title=2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \|journal=J Am Coll Cardiol \|volume=80 \|issue=24 \|pages=e223–e393 \|date=December 2022 \|pmid=36334952 \|pmc=9860464 \|doi=10.1016/j.jacc.2022.08.004 \|url=}}</ref> <ref name="url2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC">{{cite web \|url=https://www.jacc.org/doi/10.1016/j.jacc.2022.08.004 \|title=2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC \|format= \|work= \|accessdate=}}</ref> ==		==2022 ACC/AHA Guidelines for the Diagnosis and Management of Aortic Disease <ref name="pmid36334952">{{cite journal \|vauthors=Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ \|title=2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \|journal=J Am Coll Cardiol \|volume=80 \|issue=24 \|pages=e223–e393 \|date=December 2022 \|pmid=36334952 \|pmc=9860464 \|doi=10.1016/j.jacc.2022.08.004 \|url=}}</ref> <ref name="url2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC">{{cite web \|url=https://www.jacc.org/doi/10.1016/j.jacc.2022.08.004 \|title=2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC \|format= \|work= \|accessdate=}}</ref>==

	=== Multidisciplinary Aortic Team and Shared Decision-Making<ref name="url2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC" /> ===		=== Multidisciplinary Aortic Team and Shared Decision-Making<ref name="url2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines \| JACC" /> ===
Line 185:		Line 185:

	== '''References''' ==		== '''References''' ==
			<references />

Datopotamab deruxtecan-dlnk

2026-04-28T00:58:04Z

Show changes

Sandbox

2026-04-28T00:07:58Z

Multidisciplinary Aortic Team and Shared Decision-Making[2]

Show changes